Rhythm Pharmaceuticals, Inc.
RYTM
$104.46
$3.073.03%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 25.73% | 29.42% | 38.39% | -41.11% | -39.56% |
| Total Depreciation and Amortization | -9.27% | -7.50% | -9.67% | -11.09% | -10.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -41.92% | -50.67% | -62.95% | 220.78% | 175.49% |
| Change in Net Operating Assets | 7.06% | 284.55% | 3,695.56% | 119.99% | 587.18% |
| Cash from Operations | 12.29% | 16.14% | 19.21% | 16.36% | 11.62% |
| Capital Expenditure | -- | -- | -- | -- | 102.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -213.43% | 118.07% | -1,002.06% | -757.48% | 32.36% |
| Cash from Investing | -213.44% | 118.07% | -1,002.06% | -750.36% | 32.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,341.67% | 37.74% | 36.83% | -1.75% | -73.42% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -100.00% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -562.51% | -170.66% | -137.53% | -123.57% | -116.38% |
| Cash from Financing | 66.89% | -67.94% | 178.75% | 157.16% | 73.93% |
| Foreign Exchange rate Adjustments | 185.69% | 119.10% | 123.75% | 101.41% | -2,434.00% |
| Miscellaneous Cash Flow Adjustments | 200.00% | -- | -- | -- | -- |
| Net Change in Cash | 128.14% | -156.41% | 193.89% | 143.19% | 85.94% |